Download PDF

Other users also viewed these articles

Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023 Linda E. Munoz-Espinosa; Aldo Torre; Laura Cisneros; Iaarah Montalvo-Gordon; René Malé-Velázquez; Scherezada Mejía; Juan Ramón Aguilar-Ramírez; Javier Lizardi-Cervera; María E. Icaza-Chávez; Frida Gasca-Díaz; Larissa Hernández-Hernández; Paula Cordero-Perez; Luis A. Chi-Cervera; Lilian Torres-Made; Fátima Rodríguez-Álvarez; Graciela Tapia; Jorge Luis Poo;
Ann Hepatol. 2024;29 Supl 2:
Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990¿2050 Yujiao Deng; Jingyue Tan; Jian Zu; Zixuan Xing; Zhanpeng Yang; Yue Zhang; Yajing Bo; Xu Gao; Enrui Xie; Yuan Wang; Meijuan Han; Fanpu Ji; Yang Yang;
Ann Hepatol. 2026;31:
Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;
10.1016/j.aohep.2025.102158